mbiomics

mbiomics is a microbiomics biotechnology company headquartered in Munich, Germany, focusing on developing the first generation of effective Live Bacterial Therapies (LBT). It uses its proprietary high-resolution analytical platform and computational technology to generate precise data on microbiome modulation, select better-informed consortia, improve patient stratification and patient monitoring in clinical trials, enabling robust and comparable gut microbiome analysis.